Journal of
Medicinal Plants Research

  • Abbreviation: J. Med. Plants Res.
  • Language: English
  • ISSN: 1996-0875
  • DOI: 10.5897/JMPR
  • Start Year: 2007
  • Published Articles: 3843

Full Length Research Paper

Pharmaceutical prospecting of natural products from the genus Amberboa

Sher Bahadar Khan1, 2, Kalsoom Akhtar3, Abdul Malik4, Eui Sung Jang1 and Haksoo Han1*
1Department of Chemical and Biomolecular Engineering, Yonsei University, 262 Seongsanno, Seodaemun-gu, Seoul 120-749, South Korea. 2Department of Chemistry, Faculty of Science, Najran University, P. O. Box 1988, Najran, Saudi Arabia. 3ICCBS, HEJ Research Institute of Chemistry, University of Karachi, Pakistan. 4Division of Nano Sciences and Department of Chemistry, Ewha Womans University, Seoul 120-750, Korea.
Email: [email protected]

  •  Accepted: 24 February 2010
  •  Published: 04 June 2010

Abstract

Pharmaceuticals have attracted increased attention because of their beneficial effects on human health. A large number of secondary metabolites with various biological activities have been discovered but the potential for industrial development as drugs and nutritional supplements are limited. However, some bioactive substances derived from plants have diverse functional roles as secondary metabolites and these properties can be applied to the developments of novel pharmaceuticals. Recently, extensive studies have been conducted on the general aspects of the chemical structures, physical and biochemical properties and biotechnological applications of bioactive substances derived from various plants. In this research, we have summarized the pharmaceutical prospecting of natural compounds such as cycloartanes, flavonoids, sesquiterpenes, fatty acids, lignans, sterols and other metabolites isolated from genus Amberboa and their progresses in the biotechnological applications as pharmaceuticals.

 

Key words: Cycloartane, flavonoids, sesquiterpenes, fatty acids, lignans, sterols, other metabolites, pharmaceuticals, Amberboa.